This site uses cookies for analytics and to improve your experience. By clicking Accept, you consent to our use of cookies. Learn more in our privacy policy.

Subscribe
Watch

TME Pharma provides update on its activities

TME Pharma enters final evaluation phase with two potential partners for licensing lead asset NOX-A12 to support Phase 2 glioblastoma development Source: TME Pharma provides update on its activities

Globe News Wire Avatar

by

Globe News Wire
1 minute

Read Time

TME Pharma enters final evaluation phase with two potential partners for licensing lead asset NOX-A12 to support Phase 2 glioblastoma development

Source: TME Pharma provides update on its activities

Tags: ,

Previous Post

Next Post

Latest News

View All

About the Author

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

You May Have Missed

View All